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A growing body of evidence based on in vitro studies indicates that mitophagy (selective
autophagic clearance of damaged mitochondria) is a prosurvival mechanism associated
with cellular exposure to various mitochondrial stressors. Very recently, a limited
number of publications on animal-based models of alcoholic fatty liver diseases have
reported that Parkin-mediated mitophagy may mitigate hepatocyte apoptosis, improve
mitochondrial quality and suppress steatosis (lipid accumulation). From this perspective,
the authors focus on the mechanisms of Parkin mitochondrial translocation (a key
consideration in mitophagy activation) and therapeutic implications of mitophagy in liver
disease. DNA repair and other functions of Parkin beyond mitophagy are also briefly
discussed. The paper additionally shows original data from the authors’ current research
indicating enhanced hepatic mitophagy in ethanol-treated rats, which is associated with
Parkin mitochondrial translocation triggered by oxidative mitochondrial DNA damage.
Natural or pharmaceutical products that may trigger Parkin mitochondrial translocation
in hepatocytes and/or suppress repressors of such translocation could be a potential
therapeutic target in alcoholic and non-alcoholic fatty liver disease.
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THE PINK1–PARKIN PATHWAY IN MITOPHAGY
Autophagy (macroautophagy) is a prosurvival pathway for lysosomal degradation of most
cellular components in response to diverse conditions of stress, such as oxidative stress, DNA
damage, and lipid overload. Selective autophagic elimination of proapoptotic mitochondria is
called mitophagy (Eid et al., 2013b; Lemasters, 2014). The PINK1/Parkin pathway involves the
interplay of two recessive Parkinson’s-linked genes [PTEN-induced kinase 1 (PINK1) and Parkin
(an E3 ubiquitin ligase)], which maintain mitochondrial homeostasis and clear dysfunctional
mitochondria via mitophagy. Mutations affecting PINK1–Parkin genes cause Parkinson’s disease
(PD; a neurodegenerative illness characterized by accumulation of dysfunctional mitochondria). In
mammals, various effectors (including the mitophagy receptors NIX and BNIP3 and the PINK1–
Parkin pathway) contribute to the elimination of damaged mitochondria under exposure to
mitochondrial damaging agents (Youle and Narendra, 2011; Amadoro et al., 2014).
In healthy mammalian cells, the mitochondrial level of PINK1 is very low, while Parkin
normally resides in the cytoplasm (Youle and Narendra, 2011; Eid et al., 2013a; Amadoro
et al., 2014). Mitophagy is initiated by accumulation of PINK1 at the outer membrane of
damaged mitochondria, resulting in the recruitment of cytoplasmic Parkin to those mitochondria.
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The PINK1–Parkin interaction in damaged mitochondria
promotes mitophagy through protein ubiquitination and
subsequent mitochondrial fragmentation and engulfment of
mitochondria by LC3-mediated autophagosomes forming
mitophagosomes. The latter fuse with lysosomes forming
mitophagolysosomes with specific perinuclear localization (Eid
et al., 2013a; Kim et al., 2013; Amadoro et al., 2014; Lemasters,
2014). Based mostly on in vitro studies, it is considered that
various mechanisms (such as oxidative stress and mitochondrial
depolarization/fission) and mitochondrial DNA (mtDNA)
damage may activate mitophagy (Amadoro et al., 2014;
Schneider and Cuervo, 2014; Zhang, 2015). Importantly, in
consideration of similar mechanisms in various animal-based
models, acute and chronic ethanol consumption has recently
been reported to stimulate hepatic mitophagy resulting in
reduction of steatosis and apoptosis (Ding et al., 2010; Eid et al.,
2013a,b; Lin et al., 2013; Zhong et al., 2014; Williams et al.,
2015).
ETHANOL-INDUCED HEPATIC
MITOPHAGY IS ASSOCIATED WITH
PARKIN MITOCHONDRIAL
TRANSLOCATION TRIGGERED BY
OXIDATIVE DNA DAMAGE
Immunoelectron microscopy (IEM) techniques play important
roles in the exploration of components and trafficking in
autophagic machinery, especially in relation to membranous
structures that can only be clearly identified and localized using
electron microscopes (Eskelinen et al., 2011; Lenzi et al., 2012;
Eid et al., 2013a). As most research on Parkin-related mitophagy
has involved the examination of cultured neuronal cells with
focus on downstream signaling events in mitophagy, upstream
signaling pathways remain comparatively poorly characterized
(Grenier et al., 2013). Based on various light and electron
microscopic techniques, the authors recently investigated the
mechanism behind the triggering of Parkin mitochondrial
translocation and mitophagy induction using a model rat liver
with exposure to ethanol binge conditions (Nogales et al.,
2014; Eid et al., 2016). As shown in Figure 1, compared
to the control hepatocyte (Figure 1A), a marked increase
in the number of mitophagic vacuoles (mitophagosomes and
mitophagolysosomes; Figure 1B) was observed in the majority
of normal hepatocytes in ethanol-treated rats (ETRs) within
6 h of a single intraperitoneal injection of ethanol (5 g/kg).
However, the level of apoptotic hepatocytes was very low (data
not shown). This enhanced mitophagy of ETRs hepatocytes
was associated Parkin mitochondrial translocation as shown by
IEM (Figures 1C,D) and immunofluorescence double labeling of
Parkin and cytochrome c (Figures 1E,F). Also, Parkin also was
detected clearly in mitophagosomes as shown in Supplementary
Figure S1. Interestingly in ETRs, and as a novel unreported
finding revealed by IEM, Parkin was observed to be selectively
translocated to hepatocyte mitochondria and mitophagosomes
enriched with 8-OHdG, which is a marker of oxidative mtDNA
damage and mutagenicity (Gao et al., 2004; Guo et al., 2008)
(Figure 2). We confirmed this colocalization of Parkin and
8-OHdG using immunofluorescence double labeling technique
(Eid et al., 2016). Moreover, as shown in the control hepatocytes,
Parkin expression was low and cytoplasmic, while the expression
of 8-OHdG was very weak. Accordingly, consideration is
required to determine the significance of Parkin co-localization
with accumulated 8-OHdG in hepatocyte mitochondria of
ETRs. In particular, there is a need for further research to
establish whether there is simply a relation to the activation
of cytoprotective mitophagy or whether Parkin serves other
functions beyond mitophagy.
PARKIN CO-LOCALIZATION WITH
8-OHdG IN ETR HEPATOCYTES:
RELEVANCE TO MITOPHAGY
Parkin co-localization with accumulated 8-OHdG in hepatocyte
mitochondria of ETRs (Figure 2) may be a signal for mitophagy
induction and formation of mitophagosomes via the triggering of
Parkin mitochondrial translocation (Youle and Narendra, 2011;
Zhang, 2015; Eid et al., 2016). This may be supported by the
study of Gmitterová et al. (2009), who reported an increase in
8-OHdG levels in the brain and peripheral tissues of PD patients,
where Parkin mutations are common (Youle and Narendra, 2011;
Amadoro et al., 2014). In addition, the co-localization of Parkin
and 8-OHdG may represent an ideal method for monitoring
mitophagy compared with other methods involving Parkin co-
localization with outer mitochondrial proteins because the latter
proteins could be degraded by proteasome rather than mitophagy
(Yoshii et al., 2011).
POSSIBLE FUNCTIONS OF PARKIN
BEYOND MITOPHAGY
Parkin co-localization with accumulated 8-OHdG in hepatocyte
mitochondria of ETRs may be a stimulus for DNA repair
and prevention of oncogenesis, as endogenous Parkin has a
reported physical association with mtDNA (Rothfuss et al., 2009)
and translocates to nuclei in cultured neuronal cells affected
by oxidative DNA damage (Kao, 2009). Recent studies have
also revealed further functions of mitochondrial Parkin in cell
lines exposed to various stressors, including the suppression
of mitochondrial spheroid formation (Yin and Ding, 2013;
Eid et al., 2015; Khalil et al., 2015) and enhancement of
mitochondrial-derived vesicle formation under oxidative stress
(McLelland et al., 2014), stimulation of the selective escape of
antiapoptotic proteins from mitochondria to the endoplasmic
reticulum during mitophagy in stressed cells (Saita et al.,
2013), and donation of mitochondrial-derived autophagosomal
membranes in drug-treated breast cancer cells (Cook et al.,
2014). Further studies in animal models of fatty liver disease
are needed to investigate these functions of Parkin beyond
mitophagy.
Frontiers in Pharmacology | www.frontiersin.org 2 April 2016 | Volume 7 | Article 100
fphar-07-00100 May 2, 2016 Time: 13:25 # 3
Eid et al. Parkin Mitochondrial Translocation in Hepatocytes
FIGURE 1 | Enhanced mitophagy in hepatocytes of ETRs. (A,B) TEM of control (A) and ETRs (B). The short black arrows indicate mitophagosomes, while the
long black arrows show mitophagolysosomes. (C,D) IEM of Parkin in control (C) and ETRs (D). Yellow arrows indicate 25 nm Parkin immunogold particles.
(E,F) Immunofluorescence double labeling of Parkin (Red) and cytochrome c (green) in control (E) and ETRs (F). The white arrows show colocalization signals on
merging (yellow) in magnified areas below. Note that DAPI (blue) is for nuclear counterstaining.
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FIGURE 2 | Parkin translocation to mitochondria and mitophagosomes with accumulated 8-OHdG in hepatocytes of ETRs. (A) Control while (B–D),
ETRs. The boxed areas in C and D are magnified on the right. The long and short arrows indicate Parkin (25 nm) and 8-OHdG (6 nm) immunogold particles,
respectively. M, mitochondrion. The method of post-embedding immunogold double labeling of Parkin (NB100-91921) and 8-OHdG (N45.1) was performed
according to the manufacturer’s protocols (Aurion, Wageningen, Netherlands; http://www.aurion.nl/products/gold_sols.php) and recent publications (Eid et al.,
2013a, 2016).
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PHARMACOLOGICAL MANIPULATION
OF PARKIN AS A POTENTIAL
THERAPEUTIC TARGET IN FATTY LIVER
DISEASE
A cumulative body of evidence indicates that the mitochondrion
is the main target for alcohol toxicity (Hoek et al., 2002).
Accordingly, the use of autophagy and/or mitophagy inducers
may represent a suitable strategy for improving mitochondrial
function in alcoholic fatty liver (AFL) and non-alcoholic
fatty liver (NAFL) disease. The activation of autophagy
through mTOR inhibitor rapamycin has been shown to
enhance autophagic removal of damaged mitochondria in
PD (Siddiqui et al., 2012). Lin et al. (2013) found that
pharmacological promotion of autophagy by carbamazepine
or rapamycin enhanced lipophagy and possibly mitophagy
in animal models of AFL and NAFL disease, and that
it subsequently alleviated steatosis and hepatocyte damage.
Natural or pharmacological stimulation of mitophagy via the
upregulation of Parkin expression and/or its mitochondrial
translocation may represent a promising therapeutic target in
relation to AFL and NAFL disease. The specific transcription
factors that may upregulate Parkin expression in ETR hepatocytes
may be linked to the FOXO3a signaling pathway, as FOXO3a
has been reported to enhance the expression of LC3 in
hepatocytes of ethanol-treated mice (Ni et al., 2013) and
to stimulate PINK1–Parkin-mediated mitophagy with grape-
derived antioxidant in stressed heart tissue (Das et al., 2014).
The results of a recent study (Yu et al., 2016) indicated
that quercetin suppressed chronic ethanol-induced hepatic
mitochondrial damage in mice by activating mitophagy via
Parkin overexpression, which was mediated by increased
nuclear translocation of FOXO3a. As recently reported by the
authors of this paper, PINK1 overexpression on hepatocyte
mitochondrial outer membranes of acute and chronic ETRs
may be a major sensor for Parkin mitochondrial translocation
and recognition of damaged mitochondria by autophagic
machinery (Eid et al., 2013a, 2015, 2016). Meanwhile, it has
also been found that Parkin mitochondrial translocation may
be repressed by cytoplasmic P53, thus preventing mitophagy
induction in the myocardial muscle of stressed mice (Hoshino
et al., 2013). Suppression of Parkin mitochondrial translocation
repressors may therefore stimulate mitophagy and could be
of therapeutic importance in hepatosteatosis. Treatment of
ob/ob mice (a genetic model for NAFL) with metformin
was found to enhance prosurvival mitophagy in hepatocytes
by suppressing the inhibitory interaction of cytosolic p53
with Parkin, allowing Parkin mitochondrial translocation and
increasing the degradation of mitofusins (Song et al., 2016).
However, certain precautions should be considered in relation
to the stimulation of mitophagy in AFL associated with
viral infection because some studies have found that the
hepatitis C virus may induce mitophagy in hepatocytes as a
prosurvival mechanism, conferring protection and stimulating
viral multiplication (Osna et al., 2011; Kim et al., 2013).
CONCLUSION
The proper understanding of the molecular mechanisms of
mitophagy may be essential for the treatment of fatty liver
disease induced by or associated with mitochondrial damage.
IEM may be a powerful tool for detecting changes in subcellular
localization of mitophagy proteins under various conditions,
which may have diagnostic and therapeutic implications.
Selective stimulation of Parkin-mediated mitophagy via
the enhancement of its expression and/or mitochondrial
translocation using natural or pharmaceutical products may have
therapeutic potential for improving mitochondrial quality and
survival, suppressing steatosis and preventing mutagenicity in
fatty liver disease.
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